Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc A Suchard

Showing results (351-360 of 403) with videos related to

Pageof 41
Sort By:
JAMA Network Open|March 24, 2022
Analysis of Dual Combination Therapies Used in Treatment of Hypertension in a Multinational CohortYuan Lu, Mui Van Zandt, Yun Liu, et al.
Science (New York, N.Y.)|July 26, 2022
The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2Jonathan E Pekar, Andrew Magee, Edyth Parker, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2025
Comparative Safety of Second-Line Antihyperglycemic Agents in Older Adults with Type 2 Diabetes: A Multinational Real-World Evidence From LEGEND-T2DMChungsoo Kim, Fan Bu, Clair Blacketer, et al.
Nature Communications|April 4, 2026
Real-world evidence for comparative safety of second-line antihyperglycemic agents in older adults with type 2 diabetesChungsoo Kim, Fan Bu, Clair Blacketer, et al.
BMJ Open|December 23, 2021
Characteristics and outcomes of patients with COVID-19 with and without prevalent hypertension: a multinational cohort studyCarlen Reyes, Andrea Pistillo, Sergio Fernández-Bertolín, et al.
Medrxiv : the Preprint Server for Health Sciences|June 27, 2020
Renin-angiotensin system blockers and susceptibility to COVID-19: a multinational open science cohort studyDaniel R Morales, Mitchell M Conover, Seng Chan You, et al.
Ophthalmology. Retina|March 22, 2024
Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab: An Observational Health Data Sciences and Informatics Network StudyCindy X Cai, Akihiko Nishimura, Mary G Bowring, et al.
The Lancet. Digital Health|December 21, 2020
Renin-angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysisDaniel R Morales, Mitchell M Conover, Seng Chan You, et al.
Journal of the American Medical Informatics Association : JAMIA|February 24, 2023
Reproducible variability: assessing investigator discordance across 9 research teams attempting to reproduce the same observational studyAnna Ostropolets, Yasser Albogami, Mitchell Conover, et al.
Research Square|January 4, 2022
Context-specific emergence and growth of the SARS-CoV-2 Delta variantJohn T McCrone, Verity Hill, Sumali Bajaj, et al.
Pageof 41

Showing results (351-360 of 403) with videos related to

Sort By:
Pageof 41
JAMA Network Open|March 24, 2022
Analysis of Dual Combination Therapies Used in Treatment of Hypertension in a Multinational CohortYuan Lu, Mui Van Zandt, Yun Liu, et al.
Science (New York, N.Y.)|July 26, 2022
The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2Jonathan E Pekar, Andrew Magee, Edyth Parker, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2025
Comparative Safety of Second-Line Antihyperglycemic Agents in Older Adults with Type 2 Diabetes: A Multinational Real-World Evidence From LEGEND-T2DMChungsoo Kim, Fan Bu, Clair Blacketer, et al.
Nature Communications|April 4, 2026
Real-world evidence for comparative safety of second-line antihyperglycemic agents in older adults with type 2 diabetesChungsoo Kim, Fan Bu, Clair Blacketer, et al.
BMJ Open|December 23, 2021
Characteristics and outcomes of patients with COVID-19 with and without prevalent hypertension: a multinational cohort studyCarlen Reyes, Andrea Pistillo, Sergio Fernández-Bertolín, et al.
Medrxiv : the Preprint Server for Health Sciences|June 27, 2020
Renin-angiotensin system blockers and susceptibility to COVID-19: a multinational open science cohort studyDaniel R Morales, Mitchell M Conover, Seng Chan You, et al.
Ophthalmology. Retina|March 22, 2024
Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab: An Observational Health Data Sciences and Informatics Network StudyCindy X Cai, Akihiko Nishimura, Mary G Bowring, et al.
The Lancet. Digital Health|December 21, 2020
Renin-angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysisDaniel R Morales, Mitchell M Conover, Seng Chan You, et al.
Journal of the American Medical Informatics Association : JAMIA|February 24, 2023
Reproducible variability: assessing investigator discordance across 9 research teams attempting to reproduce the same observational studyAnna Ostropolets, Yasser Albogami, Mitchell Conover, et al.
Research Square|January 4, 2022
Context-specific emergence and growth of the SARS-CoV-2 Delta variantJohn T McCrone, Verity Hill, Sumali Bajaj, et al.
Pageof 41